{"id":"placebo-as-capsules","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL1231533","moleculeType":"Small molecule","molecularWeight":"285.23"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo is an inert substance used as a control in clinical trials. Any observed effects result from patient expectation, the therapeutic context, and natural disease progression rather than direct molecular action. Placebo responses can be substantial in certain conditions, particularly those with subjective symptom components.","oneSentence":"Placebo has no active pharmacological mechanism; it produces therapeutic effects through psychological and psychophysiological processes.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:26:36.733Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control arm in phase 3 clinical trials (specific indication unknown)"}]},"trialDetails":[{"nctId":"NCT06898606","phase":"PHASE1, PHASE2","title":"Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory Depression","status":"RECRUITING","sponsor":"Federal University of Latin American Integration","startDate":"2024-09-05","conditions":"Depressive Disorder","enrollment":24},{"nctId":"NCT04199104","phase":"PHASE3","title":"A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (MK-7902-010) (KEYNOTE-010)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2020-02-05","conditions":"Head and Neck Squamous Cell Carcinoma","enrollment":511},{"nctId":"NCT07498712","phase":"NA","title":"Effect of L. Reuteri LM1063 on Sleep Health Improvement","status":"RECRUITING","sponsor":"Lactomason Co., Ltd.","startDate":"2025-07-14","conditions":"Sleep Quality, Sleep Wake Disorders","enrollment":80},{"nctId":"NCT07495592","phase":"NA","title":"The Acute Effects of Onnit Alpha Brain on Cognition and Mood States","status":"NOT_YET_RECRUITING","sponsor":"Applied Science & Performance Institute","startDate":"2026-04-16","conditions":"Cognitive, Mood and Cognitive Performance, Sleep Deprivation","enrollment":34},{"nctId":"NCT03947827","phase":"PHASE3","title":"Minocycline as Adjunctive Treatment for Treatment Resistant Depression","status":"COMPLETED","sponsor":"Centre for Addiction and Mental Health","startDate":"2020-02-01","conditions":"Treatment Resistant Depression","enrollment":76},{"nctId":"NCT07496177","phase":"PHASE2","title":"A Mechanistic Study on the Effect of HTD1801 Versus Placebo on Kidney Function in Patients With Type 2 Diabetes and Chronic Kidney Disease.","status":"NOT_YET_RECRUITING","sponsor":"Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences","startDate":"2026-05-01","conditions":"T2DM, CKD","enrollment":75},{"nctId":"NCT04734080","phase":"PHASE4","title":"Dronabinol in Total Knee Arthroplasty (TKA)","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2021-03-09","conditions":"Total Knee Arthroplasty, Opioid Use","enrollment":114},{"nctId":"NCT07498751","phase":"PHASE1","title":"Phase I PK and Safety Study of Ondansetron Inhalation Powder","status":"COMPLETED","sponsor":"Luxena Pharmaceuticals, Inc.","startDate":"2025-03-13","conditions":"Postoperative Nausea and Vomiting","enrollment":24},{"nctId":"NCT07284316","phase":"PHASE2, PHASE3","title":"Effect of a Multidomain Intervention Plus Turmeric on the Prevention of Cognitive Decline in People Over 55 Years of Age With Insulin Resistance.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Instituto Mexicano del Seguro Social","startDate":"2025-02-20","conditions":"Cognitive Decline, Subjective Cognitive Impairment, Insulin Resistance","enrollment":100},{"nctId":"NCT06610968","phase":"NA","title":"Acute Vitamin D Supplementation on Testosterone in Females","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Southern California","startDate":"2025-07-01","conditions":"Female Hormone Profile","enrollment":20},{"nctId":"NCT07144293","phase":"PHASE2","title":"Improving Physical Ability and Cellular Senescence Elimination in HIV","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-12-04","conditions":"HIV, Frailty, Prefrail","enrollment":82},{"nctId":"NCT06006559","phase":"PHASE2","title":"A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue Fever","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2024-02-20","conditions":"Dengue","enrollment":108},{"nctId":"NCT07448519","phase":"NA","title":"Colonic Delivery of DIM and Perilla Oil on Gut Hormones and Food Intake in Obesity","status":"COMPLETED","sponsor":"Queen Mary University of London","startDate":"2023-06-13","conditions":"Obesity & Overweight, Appetite Regulation","enrollment":20},{"nctId":"NCT07029581","phase":"PHASE2","title":"Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis","status":"RECRUITING","sponsor":"ACADIA Pharmaceuticals Inc.","startDate":"2025-08-06","conditions":"Lewy Body Dementia Psychosis","enrollment":180},{"nctId":"NCT07300514","phase":"PHASE3","title":"Golidocitinib Versus Placebo as Maintenance Therapy for Peripheral T-Cell Lymphoma","status":"NOT_YET_RECRUITING","sponsor":"Fudan University","startDate":"2026-03-30","conditions":"Maintenance Treatment of Peripheral T-cell Lymphoma","enrollment":136},{"nctId":"NCT07487909","phase":"PHASE1, PHASE2","title":"A Study of SJP-001 in Comparison With Fexofenadine and Naproxen Administered With Alcohol","status":"COMPLETED","sponsor":"Sen-Jam Pharmaceutical","startDate":"2025-09-30","conditions":"Healthy","enrollment":47},{"nctId":"NCT06944145","phase":"PHASE2","title":"New Treatment Strategies and Epigenetic Biomarker for Management of Benign Prostatic Hyperplasia","status":"RECRUITING","sponsor":"Beth Israel Deaconess Medical Center","startDate":"2025-12-03","conditions":"BPH (Benign Prostatic Hyperplasia), Lower Urinary Track Symptoms","enrollment":242},{"nctId":"NCT05421858","phase":"PHASE3","title":"A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis.","status":"RECRUITING","sponsor":"Basilea Pharmaceutica","startDate":"2024-12-11","conditions":"Candidemia, Candidiasis, Invasive","enrollment":450},{"nctId":"NCT05430152","phase":"PHASE2","title":"Low-dose Naltrexone for Post-COVID Fatigue Syndrome","status":"COMPLETED","sponsor":"Luis Nacul","startDate":"2024-01-15","conditions":"Post-Viral Fatigue Syndrome","enrollment":160},{"nctId":"NCT07485296","phase":"PHASE2","title":"Effect of Postbiotics on Microbiota and Systemic Immunomodulation of Pembrolizumab as First-Line Therapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (RM HNSCC)","status":"RECRUITING","sponsor":"Gruppo Oncologico del Nord-Ovest","startDate":"2026-01-27","conditions":"Head & Neck Squamous Cell Carcinoma","enrollment":45},{"nctId":"NCT04191096","phase":"PHASE3","title":"Efficacy and Safety of Pembrolizumab (MK-3475) Plus Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (MK-3475-991/KEYNOTE-991)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2020-02-12","conditions":"Metastatic Hormone-Sensitive Prostate Cancer","enrollment":1251},{"nctId":"NCT07481578","phase":"NA","title":"Impact of Training Load on the Gut miCrobiome And Its Relation to exeRcise Performance, mUscle Phenotype, and markerS of Overreaching in Healthy Men","status":"RECRUITING","sponsor":"Stefan De Smet","startDate":"2024-10-07","conditions":"Exercise, Overreaching, Butyrate","enrollment":45},{"nctId":"NCT07482644","phase":"NA","title":"Efficacy and Safety of an Essential Oil-Based Product System for Immune Support","status":"NOT_YET_RECRUITING","sponsor":"dōTERRA International","startDate":"2026-05-04","conditions":"Immune System Function, Inflammation","enrollment":40},{"nctId":"NCT07479173","phase":"NA","title":"Effects of P24 on Postprandial Aminoacidemia","status":"NOT_YET_RECRUITING","sponsor":"Amplifye","startDate":"2026-05-01","conditions":"Postprandial Amino Acid Concentrations in Healthy Adults","enrollment":30},{"nctId":"NCT07483398","phase":"PHASE4","title":"RELIEF-PD: Crisugabalin for Nociplastic Pain in Parkinson's Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Guangdong Provincial People's Hospital","startDate":"2026-03-13","conditions":"Parkinson's Disease With Nociceptive Pain","enrollment":166},{"nctId":"NCT07479875","phase":"NA","title":"Caffeine Supplementation and Strength Endurance in Brazilian Jiu-jitsu Athletes","status":"COMPLETED","sponsor":"Federal University of Minas Gerais","startDate":"2025-12-12","conditions":"Muscle Strength, Physical Endurance, Exercise","enrollment":15},{"nctId":"NCT07481422","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Lyophilized Faecal Microbiota Transplantation Via Capsules in Treatment of Irritable Bowel Syndrome","status":"RECRUITING","sponsor":"University of Rijeka","startDate":"2026-03-15","conditions":"Irritable Bowel Syndrome (IBS)","enrollment":70},{"nctId":"NCT07263022","phase":"PHASE3","title":"Cognitive Strategies in Early Psychosis 2","status":"NOT_YET_RECRUITING","sponsor":"University of Minnesota","startDate":"2026-04-13","conditions":"Psychosis, Schizophrenia Disorder, Schizoaffective Disorder","enrollment":24},{"nctId":"NCT05653258","phase":"PHASE2, PHASE3","title":"Single Nuclei RNA-seq to Map Adipose Cellular Populations and Senescent Cells in Older Subjects","status":"RECRUITING","sponsor":"Cedars-Sinai Medical Center","startDate":"2023-10-17","conditions":"Obesity, Healthy Lifestyle","enrollment":160},{"nctId":"NCT07480018","phase":"NA","title":"Berberine Supplementation, Sprint Interval Training, and Immune Function Study","status":"RECRUITING","sponsor":"University of Northern Colorado","startDate":"2026-01-01","conditions":"Berberine, Sprint Training, Wellbeing","enrollment":40},{"nctId":"NCT07469462","phase":"NA","title":"The Effects of High-dose Vitamin B6 on Depression and Anxiety Symptoms","status":"RECRUITING","sponsor":"University of Reading","startDate":"2026-02","conditions":"Neural Inhibition, Anxiety, Depression","enrollment":44},{"nctId":"NCT07470645","phase":"NA","title":"Effects of Probiotic Supplementation on Stress and Anxiety in Students","status":"NOT_YET_RECRUITING","sponsor":"Nordic Biotic Sp. z o.o.","startDate":"2026-04-20","conditions":"Stress, Anxiety, Sleep","enrollment":200},{"nctId":"NCT07288138","phase":"PHASE2","title":"A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)","status":"RECRUITING","sponsor":"Eccogene","startDate":"2025-12-15","conditions":"Metabolic Dysfunction-associated Steatohepatitis","enrollment":160},{"nctId":"NCT06721156","phase":"PHASE2","title":"A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2024-12-16","conditions":"Alzheimer Disease, Dementia","enrollment":350},{"nctId":"NCT06721949","phase":"PHASE2, PHASE3","title":"Taurine Supplementation in Long COVID","status":"RECRUITING","sponsor":"University of Alberta","startDate":"2025-11-18","conditions":"Long COVID","enrollment":300},{"nctId":"NCT07475065","phase":"PHASE2, PHASE3","title":"The Effect of Oral DLBS1033 in Patients With Diabetic Polyneuropathy","status":"NOT_YET_RECRUITING","sponsor":"Universitas Sebelas Maret","startDate":"2026-03-01","conditions":"Diabetic Polyneuropathy, Peripheral Nervous System Diseases, Peripheral Neuropathy","enrollment":34},{"nctId":"NCT05811351","phase":"PHASE2","title":"A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2023-03-06","conditions":"Geographic Atrophy","enrollment":305},{"nctId":"NCT07471659","phase":"NA","title":"Effect of Daily Humiome® Post LB Intake on Wellbeing in Older Individuals With Moderate Stress Levels","status":"NOT_YET_RECRUITING","sponsor":"dsm-firmenich Switzerland AG","startDate":"2026-03-01","conditions":"Stress","enrollment":200},{"nctId":"NCT06454669","phase":"PHASE2","title":"Dronabinol as an Adjunct for Reducing Pain","status":"RECRUITING","sponsor":"Christopher D. Verrico","startDate":"2024-06-15","conditions":"Low Back Pain, Chronic Pain, Back Injuries","enrollment":75},{"nctId":"NCT06231758","phase":"PHASE3","title":"Metformin Safety and Efficacy in Osteoarthritis.","status":"RECRUITING","sponsor":"Mostafa Bahaa","startDate":"2024-01-30","conditions":"Osteo Arthritis Knee","enrollment":70},{"nctId":"NCT05523323","phase":"PHASE3","title":"A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (MK-7902-010/LEAP-010)-China Extension","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2020-10-30","conditions":"Head and Neck Squamous Cell Carcinoma","enrollment":112},{"nctId":"NCT06834997","phase":"PHASE2","title":"Dronabinol As an Adjunct for Reducing Pain (DARP)-Texas Children's Hospital","status":"WITHDRAWN","sponsor":"Baylor College of Medicine","startDate":"2026-04-01","conditions":"Endometriosis, Endometriosis Related Pain, Endometriosis, Pain","enrollment":""},{"nctId":"NCT04620759","phase":"PHASE2","title":"Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder","status":"ACTIVE_NOT_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2021-04-14","conditions":"Major Depressive Disorder, Alcohol Use Disorder","enrollment":90},{"nctId":"NCT05614063","phase":"PHASE3","title":"A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures","status":"COMPLETED","sponsor":"Xenon Pharmaceuticals Inc.","startDate":"2022-11-18","conditions":"Focal Onset Seizures","enrollment":380},{"nctId":"NCT06375668","phase":"NA","title":"The Effect of the Probiotic Strains on Bone Mineral Density in Postmenopausal Women","status":"COMPLETED","sponsor":"Nordic Biotic Sp. z o.o.","startDate":"2022-03-15","conditions":"Osteoporosis, Postmenopausal, Bone Density, Low","enrollment":170},{"nctId":"NCT06214403","phase":"PHASE2","title":"Antimicrobial Resistant Organism Decolonization After Microbiome Perturbation","status":"WITHDRAWN","sponsor":"University Health Network, Toronto","startDate":"2026-07","conditions":"Gram-negative Bacteremia, Microbial Colonization, Antibiotic Resistant Infection","enrollment":""},{"nctId":"NCT07466485","phase":"PHASE2","title":"The Efficacy of Tocotrienol Rich Fraction for Liver Protection in Adult Patients With Alcoholic Fatty Liver Disease (AFLD)","status":"RECRUITING","sponsor":"Universiti Kebangsaan Malaysia Medical Centre","startDate":"2026-03-02","conditions":"Alcoholic Fatty Liver Disease","enrollment":26},{"nctId":"NCT07465653","phase":"PHASE1","title":"A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction","status":"NOT_YET_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2026-03-19","conditions":"Heart Failure With Reduced Ejection Fraction","enrollment":12},{"nctId":"NCT04760860","phase":"PHASE1, PHASE2","title":"Terazosin for Dementia With Lewy Bodies","status":"NOT_YET_RECRUITING","sponsor":"Qiang Zhang","startDate":"2027-10","conditions":"Dementia With Lewy Bodies","enrollment":40},{"nctId":"NCT05667142","phase":"PHASE3","title":"A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures","status":"RECRUITING","sponsor":"Xenon Pharmaceuticals Inc.","startDate":"2023-02-14","conditions":"Primary Generalized Tonic-Clonic Seizures","enrollment":160},{"nctId":"NCT05716100","phase":"PHASE3","title":"A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)","status":"RECRUITING","sponsor":"Xenon Pharmaceuticals Inc.","startDate":"2023-05-09","conditions":"Focal Onset Seizures","enrollment":360},{"nctId":"NCT07239336","phase":"PHASE2","title":"Study of DONQ52 in Active Celiac Disease","status":"RECRUITING","sponsor":"Chugai Pharmaceutical","startDate":"2025-12-16","conditions":"Celiac Disease","enrollment":92},{"nctId":"NCT07452744","phase":"NA","title":"Efficacy and Safety of Picroliv in Patients With Non-Alcoholic Fatty Liver Disease","status":"ENROLLING_BY_INVITATION","sponsor":"Bioagile Therapeutics Pvt. Ltd.","startDate":"2024-08-13","conditions":"Non Alcholic Fatty Liver Disease","enrollment":170},{"nctId":"NCT06720909","phase":"NA","title":"Mindfulness And Placebo for Pain (MAPP) Study","status":"RECRUITING","sponsor":"Arizona State University","startDate":"2025-01-27","conditions":"Chronic Pain","enrollment":45},{"nctId":"NCT04192136","phase":"NA","title":"NAD+ and Exercise in FA","status":"COMPLETED","sponsor":"Children's Hospital of Philadelphia","startDate":"2020-09-03","conditions":"Friedreich Ataxia 1","enrollment":75},{"nctId":"NCT02712723","phase":"PHASE2","title":"Letrozole Plus Ribociclib or Placebo as Neo-adjuvant Therapy in ER-positive, HER2-negative Early Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Qamar Khan","startDate":"2016-02","conditions":"Breast Cancer","enrollment":121},{"nctId":"NCT07459959","phase":"PHASE1, PHASE2","title":"LiO-AD: Lithium Orotate in Alzheimers Disease Feasibility, Biomarker Engagement, and Clinical Response","status":"NOT_YET_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2026-06-01","conditions":"Alzheimer s Disease","enrollment":40},{"nctId":"NCT04495725","phase":"NA","title":"Do Discounted Vouchers for Medical Cannabis Reduce Opioid Use in Adults With Pain","status":"COMPLETED","sponsor":"Vireo Health","startDate":"2020-10-06","conditions":"Opioid Use, Marijuana, Chronic Pain","enrollment":270},{"nctId":"NCT07461220","phase":"PHASE1, PHASE2","title":"Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy","status":"RECRUITING","sponsor":"Integrative Research Laboratories AB","startDate":"2026-02-18","conditions":"PARKINSON DISEASE (Disorder), Apathy, Safety","enrollment":75},{"nctId":"NCT07459829","phase":"PHASE2","title":"Study of CU06-1004 in Patients With Daibetic Macular Edema","status":"NOT_YET_RECRUITING","sponsor":"Curacle Co., Ltd.","startDate":"2026-12-01","conditions":"DME, Diabetic Macular Edema, Diabetic Macular Edema (DME)","enrollment":156},{"nctId":"NCT06937814","phase":"NA","title":"The Effect of Humiome® Post LB on Gut COMFort in healthY Adult Volunteers","status":"RECRUITING","sponsor":"dsm-firmenich Switzerland AG","startDate":"2025-06-16","conditions":"GI Issues, Bowel Movements, Gastrointestinal Symptoms","enrollment":250},{"nctId":"NCT04373473","phase":"PHASE2","title":"Evaluation the Safety and Efficacy of Lyophilized Fecal Microbiota Transplantation Administered Orally for Prevention of Relapse or Intestinal Inflammation in Adults With Ulcerative Colitis","status":"RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2020-09-14","conditions":"Adults With Ulcerative Colitis","enrollment":58},{"nctId":"NCT07458828","phase":"NA","title":"Evaluate the Efficacy and Safety of Hydrolyzed Keratin Peptide Powder on Hair Health","status":"COMPLETED","sponsor":"Dong-A Pharmaceutical","startDate":"2024-01-23","conditions":"Hair Damage, Hair Health, Hair Strength","enrollment":120},{"nctId":"NCT07457632","phase":"PHASE2","title":"Integrative Liver-Targeted Therapy for Diabetic Macular Edema: Combining Tauroursodeoxycholate and Traditional Chinese Medicine.","status":"NOT_YET_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2026-04-01","conditions":"Diabetic Macular Edema (DME)","enrollment":69},{"nctId":"NCT07140874","phase":"PHASE2","title":"Zinc as an Adjunctive Therapy for Cervical Dystonia","status":"RECRUITING","sponsor":"University of Florida","startDate":"2026-02-20","conditions":"Cervical Dystonia","enrollment":20},{"nctId":"NCT07458984","phase":"PHASE3","title":"FMT Capsules for rCDI","status":"NOT_YET_RECRUITING","sponsor":"Helsinki University Central Hospital","startDate":"2026-02-25","conditions":"Clostridioides Difficile Infection Recurrence, FMT","enrollment":76},{"nctId":"NCT07458594","phase":"NA","title":"Combined Caffeine and Rhodiola Rosea on Aerial Duel Performance in Soccer","status":"COMPLETED","sponsor":"Beijing Sport University","startDate":"2025-10-30","conditions":"Aerial Duel Performance in Soccer Players","enrollment":96},{"nctId":"NCT05367362","phase":"PHASE2","title":"Minocycline Efficacy in Improving Neurological Outcome of Patients Who Undergo Endovascular Revascularization for Acute Ischemic Stroke","status":"WITHDRAWN","sponsor":"State University of New York at Buffalo","startDate":"2025-12-01","conditions":"Acute Ischemic Stroke","enrollment":""},{"nctId":"NCT07454408","phase":"PHASE1, PHASE2","title":"Evaluation of the Outcome of Fecal Microbiota Transplantation","status":"NOT_YET_RECRUITING","sponsor":"Air Force Military Medical University, China","startDate":"2026-03-07","conditions":"Hepatic Encephalopathy, Fecal Microbiota Transplantation, TIPS","enrollment":40},{"nctId":"NCT06853665","phase":"PHASE4","title":"The TEAM Study - Treatment Efficacy for Autism/Attention Using Mixed Amphetamine","status":"RECRUITING","sponsor":"Gagan Joshi","startDate":"2026-02-01","conditions":"Attention Deficit Hyperactivity Disorder (ADHD), Autism, Autism Spectrum Disorder","enrollment":196},{"nctId":"NCT07452978","phase":"PHASE2","title":"Propranolol for Early Secondary Prevention of Post-Traumatic Stress Disorder in Women Victims of Sexual Violence","status":"NOT_YET_RECRUITING","sponsor":"University Hospital, Tours","startDate":"2026-09-01","conditions":"PTSD - Post Traumatic Stress Disorder","enrollment":34},{"nctId":"NCT07298395","phase":"PHASE2","title":"Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis","status":"RECRUITING","sponsor":"Enveda Therapeutics","startDate":"2025-12-22","conditions":"Atopic Dermatitis (AD)","enrollment":64},{"nctId":"NCT07301255","phase":"PHASE2","title":"ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults","status":"RECRUITING","sponsor":"Enveda Therapeutics","startDate":"2026-01-09","conditions":"Asthma","enrollment":50},{"nctId":"NCT05726292","phase":"PHASE2","title":"A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2025-01-06","conditions":"Prostate Cancer, Prostate Adenocarcinoma","enrollment":90},{"nctId":"NCT05534165","phase":"PHASE3","title":"Tecovirimat in Non-hospitalized Patients With Monkeypox","status":"SUSPENDED","sponsor":"Marina Klein","startDate":"2023-08-14","conditions":"Monkeypox","enrollment":120},{"nctId":"NCT06333795","phase":"NA","title":"Faecal Microbiota Transplantation Against Chronic Diarrhea in Patients With Systemic Sclerosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Aarhus","startDate":"2024-04-01","conditions":"Diarrhea, Systemic Sclerosis","enrollment":20},{"nctId":"NCT06269627","phase":"PHASE4","title":"Temporally-Resolved Electrophysiology of Acamprosate Treatment of Alcohol Use Disorder","status":"RECRUITING","sponsor":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","startDate":"2025-05-07","conditions":"Alcohol Use Disorder","enrollment":48},{"nctId":"NCT07115056","phase":"PHASE4","title":"Extended Oral Tranexamic Acid After Anterior Cruciate Ligament Reconstruction","status":"WITHDRAWN","sponsor":"Campbell Clinic","startDate":"2026-04-01","conditions":"ACL Injury, ACL Tears, ACL Surgery","enrollment":""},{"nctId":"NCT07342491","phase":"PHASE1","title":"Dasatinib for HIV-1 Reservoir Reduction","status":"NOT_YET_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2026-03-02","conditions":"HIV Infections","enrollment":14},{"nctId":"NCT07441083","phase":"NA","title":"Efficacy and Safety of Shatavari Root Extract in Women's Sexual Wellness","status":"NOT_YET_RECRUITING","sponsor":"SF Research Institute, Inc.","startDate":"2026-03-17","conditions":"Sexual Wellness, Women Health","enrollment":60},{"nctId":"NCT07441096","phase":"NA","title":"Efficacy and Safety of Shatavari Root Extract for Premenstrual Syndrome in Women","status":"NOT_YET_RECRUITING","sponsor":"SF Research Institute, Inc.","startDate":"2026-03-20","conditions":"Premenstrual Syndrome, Women Health","enrollment":60},{"nctId":"NCT07441070","phase":"NA","title":"Effect of Ashwagandha Root Extract on Stress, Anxiety, and Sleep Quality in Adults Experiencing Minority Stress","status":"NOT_YET_RECRUITING","sponsor":"SF Research Institute, Inc.","startDate":"2026-03-24","conditions":"Minority Stress, Psychological Stress, Anxiety","enrollment":80},{"nctId":"NCT07444138","phase":"NA","title":"Effects of Beetroot Extract on Blood Pressure and Exercise in Hypertensive Older Women","status":"RECRUITING","sponsor":"São Paulo State University","startDate":"2025-10-08","conditions":"Hypertension, Hypertension (HTN)","enrollment":20},{"nctId":"NCT05301608","phase":"PHASE1, PHASE2","title":"Effects of Psilocybin on Electrophysiology and the Dynamic Content of Thought","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2022-03-03","conditions":"Healthy","enrollment":30},{"nctId":"NCT05039515","phase":"PHASE2","title":"A Study to Assess the Effectiveness and Safety of 2 Dosage Regimens of Oral Fidrisertib (IPN60130) for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP).","status":"ACTIVE_NOT_RECRUITING","sponsor":"Clementia Pharmaceuticals Inc.","startDate":"2021-12-01","conditions":"Fibrodysplasia Ossificans Progressiva","enrollment":113},{"nctId":"NCT04224493","phase":"PHASE3","title":"A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.","status":"RECRUITING","sponsor":"Epizyme, Inc.","startDate":"2020-06-11","conditions":"Relapsed/Refractory Follicular Lymphoma, Follicular Lymphoma, Refractory Follicular Lymphoma","enrollment":612},{"nctId":"NCT05948020","phase":"EARLY_PHASE1","title":"Efficacy and Safety of Orally Administered Engineered Probiotics (CBT102-A) for the Treatment of Children With Phenylketonuria","status":"COMPLETED","sponsor":"Children's Hospital of Fudan University","startDate":"2023-09-02","conditions":"Phenylketonuria","enrollment":15},{"nctId":"NCT07441343","phase":"NA","title":"Effects of Polyphenol Supplementation and Exercise on Physical Performance in Older Adults","status":"RECRUITING","sponsor":"Dr. Chris McGlory, PhD","startDate":"2025-09-01","conditions":"Sarcopenia, Aging, Frailty","enrollment":40},{"nctId":"NCT07436130","phase":"NA","title":"Curcumin in Critically Ill Patients With Sepsis","status":"NOT_YET_RECRUITING","sponsor":"Hospital Civil de Guadalajara","startDate":"2026-03-01","conditions":"Sepsis","enrollment":56},{"nctId":"NCT03598309","phase":"PHASE2","title":"Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers","status":"ACTIVE_NOT_RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2019-06-05","conditions":"Lung Diseases, Lung Cancer, Protection Against","enrollment":19},{"nctId":"NCT07220252","phase":"PHASE2, PHASE3","title":"Study to Assess Effects of Ublituximab in Pediatric Participants With Relapsing Forms of Multiple Sclerosis","status":"NOT_YET_RECRUITING","sponsor":"TG Therapeutics, Inc.","startDate":"2026-03-31","conditions":"Relapsing Multiple Sclerosis","enrollment":240},{"nctId":"NCT05758896","phase":"PHASE2","title":"Study of APX-115 in Contrast Induced Acute Kidney Injury in Subjects Undergoing PCI","status":"RECRUITING","sponsor":"Aptabio Therapeutics, Inc.","startDate":"2023-12-27","conditions":"Contrast Induced Acute Kidney Injury","enrollment":280},{"nctId":"NCT07028385","phase":"PHASE2","title":"Safety and Impact of Baricitinib on Cell Surivival Pathways, HIV-1 Reservoir and Inflamation in People With HIV-1","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia","startDate":"2025-09-22","conditions":"HIV","enrollment":30},{"nctId":"NCT07216001","phase":"PHASE2","title":"Role of Omega-DEK in Childhood Apraxia of Speech","status":"NOT_YET_RECRUITING","sponsor":"Claudia R. Morris","startDate":"2026-05","conditions":"Childhood Apraxia of Speech, Verbal Apraxia, Autism","enrollment":34},{"nctId":"NCT06969287","phase":"PHASE3","title":"Mitigating Delirium With Fluvoxamine Treatment for Non-Cardiac Surgery","status":"RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2026-03-07","conditions":"Delirium, Surgery-Complications","enrollment":46},{"nctId":"NCT07133438","phase":"PHASE4","title":"Mecobalamin Combined With Anti-VEGF Intravitreal Injection for Retinal Vein Occlusion Treatment","status":"RECRUITING","sponsor":"First Affiliated Hospital of Chongqing Medical University","startDate":"2025-08-01","conditions":"Retinal Vein Occlusion (RVO)","enrollment":120},{"nctId":"NCT03016819","phase":"PHASE3","title":"Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)","status":"RECRUITING","sponsor":"Advenchen Laboratories, LLC","startDate":"2017-08-15","conditions":"Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma","enrollment":325},{"nctId":"NCT06557772","phase":"PHASE2","title":"A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi","startDate":"2024-08-29","conditions":"Coeliac Disease, Celiac Disease","enrollment":229},{"nctId":"NCT07433855","phase":"NA","title":"Efficacy and Safety of Heat-Treated Lactiplantibacillus Plantarum LM1004 on Immune Function","status":"COMPLETED","sponsor":"Soon Chun Hyang University","startDate":"2023-08-31","conditions":"Immune Function","enrollment":120},{"nctId":"NCT06131502","phase":"PHASE1, PHASE2","title":"Sonication-based OCD Neurosurgical Intervention Via Capsulotomy","status":"NOT_YET_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2026-08","conditions":"Obsessive-Compulsive Disorder","enrollment":66}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":4485,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo as Capsules","genericName":"Placebo as Capsules","companyName":"Eli Lilly and Company","companyId":"eli-lilly","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Placebo has no active pharmacological mechanism; it produces therapeutic effects through psychological and psychophysiological processes. Used for Control arm in phase 3 clinical trials (specific indication unknown).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}